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Abstract
 .In order to investigate the effect of primary amphipathic peptides on mollicutes wall-less bacteria , we have synthesised
 .five molecules P1, P2, P3, JM123, and JM133 comprising a 16 to 18-residue hydrophobic sequence and the nuclear
 .localization sequence NLS PKKKRKV of simian virus 40 large-T antigen, C-terminated by a cysteamide group. The
hydrophobic cluster was in P1 the signal sequence of the heavy chain of Caiman crocodilus immunoglobulin G and in
JM123 the fusion peptide of human immunodeficiency virus 1 glycoprotein gp41 in which phenylalanine7 was replaced by
a tryptophan residue. The homologues P2, P3, and JM133 were obtained by slight alterations of these sequences. Circular
dichroism spectroscopy revealed that, in liposomes, P-series peptides were mainly under the form of b-sheets whereas
JM-series peptides displayed a high proportion of turns. These peptides proved to be bactericidal for some mollicutes,
notably Acholeplasma laidlawii, but were much less potent than melittin. Furthermore, their antibiotic activity was
independent of the average thickness of the plasma membrane hydrophobic core whilst that of melittin was inversely related
to the thickness. Melittin and the synthetic peptides abolished spiroplasma cell motility and helicity, but only melittin and
P-series peptides split the cells into globular forms displaying an average diameter of ca. 1 mm. In contrast to melittin, the
synthetic peptides agglutinated spiroplasmas, suggesting that their polycationic NLS was exposed on the cell surface.
P-series peptides decreased, though less efficiently than melittin, A. laidlawii and Spiroplasma melliferum membrane
 .  .potential DC and transmembrane pH gradient DpH , at concentrations much lower than their minimal inhibitory
concentrations whilst JM-series peptides had no effect on DC and DpH in the same conditions. Actually, the bactericidal
 .Abbreviations: A , light absorbance at 600 nm; CD, circular dichroism; CFU, colony forming unit; cFDASE, 5 6- -carboxyfluo-600
 .  . X Xrescein diacetate succinimidyl ester; cFSE, 5 6- -carboxyfluorescein succinimidyl ester; diSC - 5 , 3,3 -dipropyl-2,2 -thiadicarbocyanine3
 .iodide; DOPG, dioleylphosphatidyl glycerol; Fmoc, fluorophenyl methoxycarbonyl; Hepes, hydroxy-2-ethyl-4-piperazinyl-1 -2-ethane
sulfonic acid; MIC, minimal inhibitory concentration; NEM, N-ethyl morpholine; NLS, nuclear localization sequence; SUV, small
 .unilamellar vesicles; Tris, Tris- hydroxymethyl -aminomethane; D I, change in fluorescence intensity; DpH, transmembrane pH gradient
 .  .DpHspH ypH ; DC , membrane electrical potential DCsC yCin out in out
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activity of these peptides towards mollicutes was proportional to their ability to collapse the electrochemical transmembrane
potential. q 1997 Elsevier Science B.V.
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1. Introduction
The most widely used defence system in nature is
that involving peptides since it seems to be shared by
 .all living organisms, from the simplest bacteria to
 . the most complex plants and animals for recent
w x.reviews see 1–8 . Though these peptide weapons
display very diverse sequences, they are most often
 .short less than 40 residues , cationic, and am-
phiphilic. They may be classified within two distinct
groups: ribosomally synthesised peptides and pep-
 .tides synthesised by multienzymatic nonribosomal
systems. Ribosomally synthesised peptides of eucary-
otes are linear, composed of only standard L-amino
 .acids, and contain disulfide bonds e.g., defensins or
 .not e.g., cecropins . Those synthesised by bacteria
 .lantibiotics contain lanthionine thioether bonds.
Nonribosomally synthesised peptides for review see
w x.  .9 may be linear e.g., peptaibols or cyclic
 .gramicidin S . The former contain unusual residues
 .e.g. a-aminoisobutyric acid and the latter D-amino
acids; both may be acylated. Most of these
attackrdefence molecules are membranotropic: Their
main target is indeed the cell plasma membrane in
which they insert and alter permeability. Many of
them have thus been described as ionophores forming
 .transmembrane ion channels e.g., alamethicin or
 .acting as shuttle carriers e.g., valinomycin . How-
ever, as in the case of melittin, peptide antibiotic
activity may also be based upon more complex mem-
w x  w x.brane structural disorders 10 for a review see 11 .
Linear peptides composed of standard L-amino
acids are particularly suited for experimental research
since they are easier to chemically synthesise than
peptides containing unusual residues. Furthermore, it
is possible to conceive a large number of variants for
investigating structureractivity relationships enan-
tio, retro, and retroenantio isomers, deletions, inser-
.tions, etc. . In this category, the amphipathic cationic
a-helix is the archetype of the pore-forming antibi-
w xotic peptide 11,12 . Hence, it is not surprising that a
large amount of research has been devoted to pep-
tides of this specific category in contrast to primary
amphipathic peptides, i.e., those in which the hy-
drophobic residues and the hydrophilic ones are seg-
regated along the sequence within two distinct clus-
ters. We have recently synthesised five linear pep-
tides comprising a 16 to 18-residue hydrophobic se-
quence corresponding to a signal sequence or to a
membrane fusion peptide, linked to the NLS nuclear
. w xlocalization sequence PKKKRKV 13,14 , C-
 .terminated by a cysteamide group Fig. 1 . Though
these peptides were initially designed for the vectori-
sation of drugs in animal cells, they provided the
opportunity of investigating the effects of primary
amphipathic peptides on bacterial cells.
Mollicutes were chosen as target bacteria because
they represent the simplest, cultivable, and self-repli-
w xcating organisms described thus far 15–17 . Their
cell envelope is composed of only the plasma mem-
brane which should facilitate the analysis of the
interactions between peptides and the bacterial cell
surface. We have recently shown that mollicutes are
much more sensitive to amphipathic peptides pro-
duced by bacteria gramicidin S, valinomycin,
.globomycin, iturin, and surfactin and fungi
 .alamethicin than to animal defence peptides such as
w xcecropins and magainin 18,19 . We believe that this
is probably one of the main reasons why mollicutes
successfully parasite such a wide range of eucaryotic
hosts as plants, insects and mammals including hu-
mans.
In this work, we have analysed the conformation
of these synthetic peptides in different conditions,
 .using circular dichroism spectroscopy CD . Their
antibacterial activity was assessed by the growth
Fig. 1. Sequences of melittin and of the five synthetic peptides
studied in this work.
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inhibition method whereas the effects on cell shape
and motility, and on the transmembrane electrochem-
ical potential were analysed using dark-field light
microscopy and spectrofluorometry. Bee-venom
w xmelittin 20 , a secondary amphipathic peptide dis-
playing a strong bactericidal activity, was used for
comparison.
2. Materials and methods
2.1. Commercial lipids and peptides
 .Dioleylphosphatidylglycerol DOPG , valino-
mycin, nigericin, and ultrapure melittin were pur-
 .chased from Sigma St. Louis, MI .
2.2. Peptide synthesis
The synthesis of the peptides was performed on
aminoethyldithio-2-isobutyric acid-Expansin with a
 .Milligen 9050 Pepsynthetizer Millipore, UK with
 .the Fmoc fluorophenyl methoxycarbonyl rtertiobu-
w xtyl system as described previously 21,22 and ac-
cording to manufacturer’s instructions. Fmoc amino
acids were activated by the addition of equimolar
 .amounts of O- 1H-benzotriazol-1-yl -N, N, N, N-te-
tramethyl-uroniumtetrafluoroborate and 1-hydroxy-
benzotriazole diluted to 0.3 M with 5.5% N-ethyl
morpholine in N, N-dimethylformamide. Coupling
was obtained by running this solution through the
reaction column for 45 min. Double couplings 45
.  14 17min were performed at crucial steps Thr , Ala ,
18 21 22 24.Arg , Lys , Arg , and Val to improve yield and
make purification easier. Fmoc deprotection was
achieved by percolating 20% piperidine in N, N-di-
methylformamide through the reaction column for 4.5
min at 3.8 ml miny1 for the first nine cycles and 1
min at 3.8 ml miny1 plus 7 min at 1.5 ml miny1 for
the end of the synthesis. After deprotection of the
terminal amino group, the side chain-protected pep-
tidyl resin was washed four times with
dichloromethane and four times with diethylether,
w xand finally was dried under vacuum 23 .
2.3. Peptide purification and analysis
The peptides were purified by analytical HPLC on
 .an Aquapore Applied Biosystems, San Jose, CA RP
 .300 column C8, 7 mm, 4.6=220 mm and by
semi-preparative HPLC on a Nucleosil SFCC,
. Neuilly-Plaisance, France 300 column C18, 5 mm,
.20=200 mm . Electrospray mass spectrometric anal-
yses were carried out in the positive ion mode using a
Trio 2000 VG Biotech Mass Spectrometer Al-
.tringham, UK . Amino acid analyses were performed
on a Model 7300 high performance analyser Beck-
.man Instruments, Fullerton, CA and Gold software
was used for the quantification. Typically, 50 nmol of
peptide was hydrolysed under vacuum in sealed glass
tubes in 0.2 ml of 5.7 N HCl containing 0.9% phenol,
at 1108C for 23 and 46 h. For tryptophan determina-
tion, hydrolysis was performed in 4 M methane
sulfonic acid for 24 h.
2.4. Circular dichroism spectroscopy
 .Circular dichroism CD measurements of peptide
solutions were recorded from 190 to 260 nm at 208C
with a Jobin–Yvon Mark V dichrograph at a scan
y1  .speed of 20 nm min in 0.1 mm peptides in SDS
 .or 1 mm peptides in water or liposomes path length
quartz cells. The peptides were analysed in 10 mM
 .sodium phosphate buffer pH 7.2 containing or not
 .SDS or liposomes see Fig. 2 for details . 5 scans
were performed per analysis and subsequently aver-
aged. Corrections were made for buffer and detergent
or lipid contribution. The Dicroprot software v2.3d
 .Gilbert Deleage, IBCP Lyon, France was used for
evaluating percentages of a-helix, b-sheet, turn and
random coil contents. The fit results were obtained by
a least square method based on the Gauss–Jordan
elimination.
2.5. Preparation of ˝esicles
 .Small unilamellar vesicles SUV were prepared
from DOPG by sonication. Briefly, dry lipids were
 .dissolved in chloroformrmethanol 3:1, volrvol .
The solvent was evaporated under a nitrogen stream
and the sample desiccated under high vacuum for at
least 3 h to remove residual solvent. The lipids were
 y1.resuspended in buffer 2 mg ml by vortex mixing
and sonicated ca. 20 min at 80% pulse cycle in an
.icerwater bath with a probe sonicator. All SUV
preparations were equilibrated overnight at 48C be-
fore use.
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2.6. Bacterial strains and growth conditions
The seven strains of mollicutes used in this study
were Acholeplasma laidlawii A-PG8, A. laidlawii
A-EF22, M. gallisepticum S6, M. genitalium G37,
M. mycoides ssp. mycoides SC KH3J, S. citri R8A2,
and S. melliferum BC3. In most experiments, these
w xbacteria were cultured as described previously 19 .
Furthermore, in order to determine the influence of
the average thickness of the hydrophobic core of the
cell membrane on peptide antibiotic activity, A. laid-
lawii A-EF22 was adapted to and grown in lipid-free
media with defined fatty acid content, as described
w x  .previously 24 see Table 3 for details .
2.7. Determination of minimal inhibitory concentra-
( )tions MICs
The mollicutes were cultured under microaerobic
conditions in appropriate liquid media as described
w xpreviously 18,19 . Minimal inhibitory concentrations
 .MICs were determined by culturing the cells in
96-well microtitration plates in the presence of 2-fold
serial dilutions of the peptides and following the
colour change of phenol red resulting from the acid-
ification of the culture medium during the growth.
The starting cell concentration was 106 colony-for-
 . y1ming units CFU ml and the assays were per-
formed in triplicate. Organisms were considered re-
sistant when their growth could not be prevented by
peptide concentrations up to 100 mM. To distinguish
bacteriostatic effects from bactericidal ones, cells
were incubated in the presence of peptides for 2 h
and plated on solid culture medium containing 1%
noble agar. The plates were subsequently incubated
and examined daily for the apparition of colonies.
2.8. Light microscopy
Exponentially growing S. melliferum BC3 cells
were sedimented by centrifugation at 10 000=g for
10 min at 48C and dispersed in 50 mM sodium
 .phosphate buffer pH 7.0 containing 50 mM D-glu-
cose and 549 mM D-sorbitol. The suspension con-
10 y1  .tained 10 CFU ml absorbance, A s1.0 . The600
effect of peptides on spiroplasma cell morphology
and motility was observed with a Leitz Diaplan mi-
croscope equipped with a 100-W halogen lamp, Leitz
 .oil immersion dark-field condenser NA 1.2 to 1.4 ,
 .Leitz PL Fluotar 100= objective NA 0.6 to 1.32 ,
and Periplan GF 12.5=r18M eyepieces. A volume
of 10 ml of cell suspension was deposited on a glass
 .slide 1=25=75 mm and covered with a glass
coverslip of 0.15=24=36 mm. Micrographs were
taken with a Nikon F-801 camera using Kodak T-Max
 .35 mm film ISO 3200 . Spiroplasma cells treated or
not with peptides were also fixed with 2.5% glu-
 .taraldehyde pH 7.0 , spread on glass slides, stained
with crystal violet, and observed as described for live
cells. In this latter case, micrographs were taken
 .using Ilford HP 5 Plus 35 mm film ISO 400 .
2.9. Fluorescence measurements of the effect of pep-
tides on cell membrane potential
Fluorescence studies were performed as described
w xpreviously 18,19,25 on A. laidlawii A-PG8 and S.
melliferum BC3. Alterations of membrane potential
by peptides were probed using the fluorescent carbo-
 .  X Xcyanine dye diSC - 5 3,3 -dipropyl-2,2 -thiadi-3
. w xcarbocyanine iodide 26 . Exponentially growing A.
laidlawii cells were harvested, washed once and dis-
 .persed in 5 mM hydroxy-2-ethyl-4-piperazinyl-1 -
2-ethane sulfonic acid pH 7.0 Hepes buffer, 150 mM
. 9 y1NaCl to obtain a cell density of 10 CFU ml
 y1.A s0.06; 20 mg of cell protein ml . Similarly,600
S. melliferum cells were washed and dispersed in 5
 .mM Hepes buffer pH 7.0, 128 mM NaCl to obtain a
9 y1 cell density of 10 CFU ml A s0.10, 30 mg of600
y1.cell protein ml . In these conditions, S. melliferum
cells conserved their helical morphology and motility
for about 30 min. A freshly prepared 0.15 mM
 .methanol solution of diSC - 5 was added to the cell3
 .suspensions 3 ml at a final concentration of 0.15
 .  .  .Fig. 2. Circular dichroism spectra of peptides P1 A and JM133 B in different media. Peptides were solubilised in buffer ‘ , buffer
 .  .containing 40 mM SDS ^ , or in buffer containing 3.1 mM DOPG I . All the measurements were performed in 10 mM sodium
 . phosphate buffer pH 7.2 . The concentration of SDS was well above its critical micelle concentration CMCs8 mM in the same
.experimental conditions . R , detergent or lipidrpeptide molar ratio.i
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mM. The fluorescence signal was measured with a
Kontron SFM 25 spectrofluorometer equipped with a
magnetic stirring holder using 5 ml quartz cuvettes 1
.cm path length maintained at 378C for A. laidlawii
and 328C for S. melliferum. Excitation and emission
wavelengths were set at 625 and 660 nm, respec-
tively. When steady-state fluorescence levels were
 .obtained, 3 ml of peptide solution in water melittin ,
 .methanol melittin, valinomycin, P1, P2, P3 , or
 . dimethylsulfoxidermethanol 1:9 volrvol JM 123,
.JM133 was added to the cell suspension. The pep-
tides were used at final concentrations ranging from 0
to 0.1 mM. The solvents for peptide and dye solubili-
sation did not interfere at the concentrations used
 .i.e., F0.2%, volrvol .
 .The calibration of dye fluorescence change %D I
 .vs. change of membrane electrical potential DC
was performed using valinomycin-induced Kq diffu-
w xsion potential 27 . This potential was calculated from
th e N e r n s t e q u a t io n DC s R T r
. w qx w qx . w qx w qxF log K r K where K and K arein out in out
the known initial potassium ion concentrations.
Potassium was determined by flame spectrometry.
Intracellular volume was determined by the method
w x w 14 x of Stock et al. 28 using carboxyl- C inulin 111
y1.  . 3MBq g DuPont NEN, Boston, MA and H O2
 y1.  .400 MBq ml Amersham, Les Ulis, France as
markers. Spiroplasma cells were centrifuged at
10 000=g for 10 min and the pellets were dispersed
in 5 mM Hepes buffer 440 mM D-sorbitol and 128
.  .mM NaCl to obtain an A of 5. Samples 500 ml600
of this suspension were incubated for 30 min in the
 5 .presence of radiolabelled inulin 10 dpm or with
 6 .tritiated water 10 dpm to determine extracellular
and total volumes of the pellets, respectively. Ra-
dioactivity was determined by liquid scintillation
counting.
2.10. Determination of intracellular pH
 .The intracellular pH of mollicutes pH was de-in
termined with the internally conjugated fluorescent
 .probe 5 6- -carboxyfluorescein succinimidyl ester
 w x.cFSE, 29 . Bacteria were grown, harvested, and
dispersed to obtain 1010 CFU mly1 of 50 mM potas-
sium-phosphate buffer pH 7.4 containing 150 mM
 . NaCl A. laidlawii or 549 mM D-sorbitol S. mel-
.liferum . The cells were then incubated in the pres-
 .  .ence of 1.0 mM 5 6- -carboxyfluorescein cFDASE .
After 10 min, the cells were washed and incubated
for further 30 min in the presence of 10 mM glucose
to remove nonconjugated cFDASE. Cells containing
the fluorescent probe were diluted 10= and 3 ml
were transferred in a 5-ml quartz cuvette placed in a
stirred and thermostated holder in the spectro-
fluorometer. Fluorescence intensities were recorded
at an emission wavelength of 520 nm whereas the
excitation was set at 490 nm. The 490-to-440 nm
ratios were corrected for background signal due to
buffer. The incubation and recording temperatures
were 328C for S. melliferum and 378C for A. laid-
lawii. At the end of each assay, the extracellular
fluorescence signal was determined in cell filtrates
 .pore diameter, 0.1 mm . Calibration curves for pH in
were determined in buffers with pH values rangingout
from 5 to 8. Buffers were prepared from glycine 50
.  . mM , citric acid 50 mM , Na HPO –2H O 502 4 2
.  .mM , and KCl 50 mM with pH being adjusted with
HCl or NaOH. In the case of S. melliferum, the
buffered solutions contained 440 mM D-sorbitol as
osmoprotectant. The pH and pH were equili-in out
brated by addition of 2 mM valinomycin and 2 mM
nigericin, and the ratios were determined as described
before.
2.11. Protein determination
Protein was determined with the method of Lowry
w x w xet al. 30 modified by Markwell et al. 31 , using
bovine serum albumin as standard.
3. Results
3.1. Sequences and conformations of the peptides
The sequences of the five synthetic peptides are
given in Fig. 1. P1 consisted in the hydrophobic
signal sequence of the heavy chain of Caiman
crocodilus immunoglobulin G and the NLS
PKKKRKV of simian virus 40 large-T antigen
w x13,14 , separated by a SQ dipeptide linker. The NLS
was C-terminated by a cysteamide group. JM133
differed from P1 by the hydrophobic sequence first
.18 residues which was the fusion peptide of human
w ximmunodeficiency virus 1 glycoprotein gp41 32 in
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which phenylalanine7 and arginine18 were replaced
 .by tryptophan residues W . As compared with
JM133, JM123 conserved arginine18 but missed the
tripeptide SQP. In comparison with P1, P3 missed the
sequence WSQP whereas P2 further missed valine9.
These peptides were analysed by CD spectroscopy to
determine their secondary structure in different me-
dia. The data listed in Table 1 were deduced from the
 .  .CD spectra of P1 Fig. 2A and JM133 Fig. 2B . In
water, P1 appeared to be mainly disordered 69%
.coil whereas in the presence of SDS micelles the
proportion of ordered structures was increased 44%
.a-helix and 13% b-sheet to the expense of coil
 .43% . However, in the presence of DOPG liposomes
 .SUV , the proportion of b-sheet was considerably
increased since it reached 80%. No turn could be
detected within P1 in any of the three media. In
comparison, JM133 was essentially under the form of
 .  .coil 60% and b-sheet 40% in water whereas in
SDS micelles and in DOPG liposomes turns appeared
to be the dominant conformation 50 and 63%, re-
.spectively . The spectra of P2 and P3 obtained in the
same conditions were quite similar to those of P1 and
the spectra of JM133 were identical to those obtained
 .with JM123 not shown .
3.2. Effect of the peptides on the growth of mollicutes
Melittin inhibited the growth of the six strains of
mollicutes, with MICs ranging from 0.78 to 12.5 mM
whereas the synthetic peptides proved much less
 .potent Table 2 . JM123 and JM133 inhibited only A.
laidlawii and M. genitalium with MICs ranging from
12.5 to 50 mM. P-series peptides proved capable of
Table 1
 .Secondary structure relative % of peptides P1 and JM133 in
different media as determined by CD spectroscopy
Peptide Helix b-Sheet Turn Coil
P1 in water 3 28 0 69
P1 in SDS 44 13 0 43
P1 in DOPG liposomes 9 80 0 11
JM133 in water 0 40 0 60
JM133 in SDS 24 13 50 13
JM133 in DOPG liposomes 9 5 63 23
Measurements were performed in 10 mM sodium phosphate
 .buffer pH 7.2 containing or not SDS or DOPG. See Fig. 2 for
experimental conditions.
Table 2
Antibiotic activity of peptides JM123, JM133, P1, P2, and P3 on
mollicutes, as compared with melittin
Peptides Al Mgl Mgn Mm Sc Sm
Melittin 0.78 6.25 6.25 12.5 0.78 1.56
JM123 25 R 50 R R R
JM133 12.5 R 50 R R R
P1 25 100 50 R 100 100
P2 6.25 50 50 R 100 100
P3 6.25 50 50 R 100 100
 .Data are expressed as minimal inhibitory concentrations MICs
y1  .in mmol l . Mollicutes were considered resistant R when they
were not inhibited by concentrations up to 100 mM. Abbrevia-
tions: Al, A. laidlawii; Mgl, M. gallisepticum; Mgn, M. geni-
talium; Mm, M. mycoides ssp. mycoides SC; Sc, S. citri; Sm, S.
melliferum. The same MICs were obtained for both strains A-PG8
.and A-EF22 of A. laidlawii.
inhibiting all the mollicutes, except M. mycoides ssp.
mycoides SC, with MICs ranging from 6.25 to 100
mM. Plating peptide-treated cells on solid medium
revealed that in all cases where inhibition occurred,
the synthetic peptides, similar to melittin, were bacte-
ricidal in spite of their lower activities.
Since A. laidlawii can be restricted to incorporat-
ing fatty acids from the growth medium into its
Table 3
Influence of A. laidlawii A-EF22 membrane thickness on the
antibiotic activity of melittin, JM123, JM133, P1, P2, and P3
Peptides Average thickness of the hydrophobic
˚ .core of the membrane A
a b c d23 25 26.3 28
Melittin 0.78 0.78 1.56 3.12
JM123 25 25 25 25
JM133 12.5 12.5 12.5 12.5
P1 25 25 25 25
P2 6.25 6.25 6.25 6.25
P3 6.25 6.25 6.25 6.25
Data are expressed as mM minimal inhibitory concentrations
 .MICs . In order to obtain the indicated thicknesses, A. laidlawii
A-EF22 was grown in lipid-free medium supplemented with:
a  .75 mM tetradecanoic acid 14:0 q75 mM cis-9-tetradecanoic
 .acid 14:1c .
b  .150 mM cis-9-hexadecanoic acid 16:1c .
c  .150 mM cis-9-octadecanoic acid 18:1c .
d  .150 mM cis-9-octadecanoic acid 18:1c q20 mM cholesterol.
These conditions give the following compositions in membrane
 .  .  .lipids: a 14:0q14:1, molar ratio, 1r1, b 100% 16:1c, c
 . w x100% 18:1c, and d 18:1cq cholesterol, molar ratio 75r25 24 .
( )L. Be˝en et al.rBiochimica et Biophysica Acta 1329 1997 357–369´364
membrane lipids, this mollicute was grown under
conditions that allowed membranes with four differ-
ent hydrophobic core thickness to be obtained: 23,
˚  .25, 26.3, and 28 A Table 3 . These figures were
2 w xpreviously determined by H-NMR spectroscopy 24 .
In contrast to melittin which inhibitory activity de-
creased with increasing the thickness of the bilayer
˚hydrophobic core from 23 to 28 A, the activities of
the five peptides were independent of membrane
thickness. It should be stressed, however, that even in
the case of the thickest cell membrane, the bacterici-
dal activity of melittin was still very high MICs3.12
.mM .
3.3. Effect of the peptides on spiroplasma motility
and cell morphology
Exponentially growing S. melliferum BC3 cells
exhibited an average helix length of 6.5"1.6 mm
with a pitch of about 1 turn mmy1. Upon treatment
with melittin, the cells progressively lost their motil-
ity and helical shape. After 5 min of incubation in 0.1
 10 y1.mM melittin, the whole population 10 CFU ml
Fig. 3. Dark-field light microscopy observation of spiroplasma
 .cell deformation. Untreated S. melliferum BC3 cells 1 are
 .compared with cells treated with 0.1 mM melittin 2 , 10 mM P1
 .  . 10 y1 3 , 10 mM JM133 4 . Cell densities were 10 CFU ml 1
. 11 y1  .and 2 and 10 CFU ml 3 and 4 . See text for details. Bar
 .top left corner in 1 , 2 mm.
Fig. 4. Time-course of spiroplasma cell deformation by melittin,
P1, and JM133. Cells were considered deformed when helicity
was lost. Whenever cell deformation occurred, it was always
preceded by the lost of cell motility. Each curve is the average of
at least three independent measurements standard deviation,
.  .SDF"5% . Symbols: untreated cells ‘ and cells treated with
 .  .  .100 mM JM 133 v , 10 mM P1 I , 100 mM P1 B , 0.1 mM
 .  .melittin ^ , or 1 mM melittin ’ .
was transformed into spherical forms having an aver-
 .age diameter of about 1 mm Figs. 3 and 4 . The
same phenomenon occurred within only a few sec-
onds when the cells were treated with 1 mM melittin.
P-series peptides exhibited the same deforming activ-
ity but the rates of deformed cells were of 70% and
90% after treatment with 10 and 100 mM peptide,
respectively. The activity of JM123 was identical to
that of JM133 but lower than the activities of the
P-series peptides: About 60% of the cells were de-
formed after 10 min of treatment with 100 mM
 .concentrations Fig. 4 . Furthermore, JM-series pep-
tides proved unable to split the cells into spherical
forms.
When the spiroplasma concentration was raised up
to 1011 CFU mly1, treatment with either of the
synthetic peptides induced a massive agglutination of
 .deformed but still filamentous cells Fig. 3 , a phe-
nomenon which was never observed with melittin.
The average size of the cells indicated than no spiro-
plasma cell fusion occurred upon peptide treatment,
even when using JM-series peptides which contain a
hydrophobic membrane fusion sequence.
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3.4. Effect of the peptides on membrane potential
In order to quantitatively determine the transmem-
 .brane electrical potential DC in A. laidlawii A-PG8
and S. melliferum BC3, we have first correlated the
 .Fig. 5. Effect of peptides on membrane electrical potential DC
 .  .in A. laidlawii A-PG8 A and S. melliferum BC3 B . The
arrows indicate the time at which the peptides were added to the
cell suspensions. Concentrations used: 1 mM for valinomycin and
0.1 mM for the other peptides. Each curve is the average of at
 .least three independent measurements SDF"8.5% .
Fig. 6. Effect of peptide concentration on the alteration of
 .membrane potential in A. laidlawii A-PG8 A and S. mel-
 .liferum BC3 B . Each point is the average of at least three
 . distinct measurements SDF"8.5% . Symbols: melittin ^ and
.  .  . ’ , P1 I and B , JM133 ‘ and v , A. laidlawii ’, B,
.  .and v , and S. melliferum ^, I, and ‘ .
 .relative fluorescence quenching D I of the carbo-
 .cyanine probe diSC - 5 and the magnitude of the3
imposed Kq diffusion potential in both mollicutes.
D I proved linearly related to DC between y95 and
y7 mV in A. laidlawii and y123 and y21 mV in
S. melliferum, which allowed a fairly good estimation
of membrane potential variations induced in these
bacteria by peptide treatment.
The fluorescence signal observed after the addition
of the probe to cell suspensions reached a constant
level after about 1 min. In the absence of peptide, a
steady fluorescence signal was recorded over at least
20 min, indicating that both A. laidlawii and S.
melliferum were capable of maintaining a constant
membrane potential in buffer containing 50 mM glu-
 .cose Fig. 5 . This membrane potential was of y50
 .mV in A. laidlawii Fig. 5A and y68 mV in S.
 .melliferum Fig. 5B . Treatment of the cells with 0.1
mM melittin induced a depolarization of the plasma
membrane in both A. laidlawii DC dropped from
w x .y50 to 0 mV, i.e., D DC s50 mV and S. mel-
 w x .liferum D DC s31 mV . The peptides P1, P2, and
 .P3 0.1 mM also depolarised the membranes of A.
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 w xlaidlawii D DC s25 mV for P1 and 36 mV for P2
.  w xand P3 and S. melliferum D DC s9 mV for P1
.and 11 mV for P2 and P3 , but to a lesser extent than
melittin. JM123 and JM133 were devoid of signifi-
cant activity when used at the same concentration
Fig. 7. Effect of peptide-treatment on the transmembrane pH
 .gradient. The intracellular pH pH of cells energised with 50in
mM glucose was determined as described in Section 2. DpHs
pH ypH , with each point being the average of at least threein out
 .independent measurements SDF"3% . Each peptide was used
 .at a concentration of 0.1 mM. Symbols: untreated cells ‘ and
 .  .  .cells treated with melittin ’ , P1 B , or JM133 v .
than melittin or P-series peptides since they induced a
drop of DC of only 2 mV in A. laidlawii whereas
no effect could be measured in S. melliferum. Fig. 6
further shows the dose-dependence of peptide-in-
duced membrane depolarisation in A. laidlawii and
S. melliferum.
3.5. Effect of the peptides on transmembrane DpH
The effect on the transmembrane pH gradient
 .DpHspH ypH was thoroughly analysed forin out
 .melittin, P1, and JM133 Fig. 7 . A. laidlawii and S.
melliferum energised with 50 mM glucose were capa-
 .ble of maintaining a DpH pH ypH )0 whichin out
proved to be stable for at least 20 min. This trans-
membrane gradient increased linearly from 0.23 to
 .1.31 in A. laidlawii Fig. 7A and from 0 to 1.34 in
 .S. melliferum Fig. 7B as the external pH was
diminished from 7.5 to 5.0. Immediately after the
 .addition of peptide 0.1 mM melittin or P1 , the DpH
increased transiently for about 2 min and then dropped
within 2 min to reach a steady value, always lower
than that observed in the absence of peptide. As
 .expected from DC measurements see above , P1
diminished the DpH in both mollicutes, but less
efficiently than melittin, whilst no effect could be
detected with JM133.
4. Discussion
The antibiotic activity of the synthetic peptides
was assessed by growth inhibition tests using six
species of mollicutes: A. laidlawii which is fre-
quently found as a contaminant in animal tissue cell
w xcultures 33 , M. gallisepticum which is pathogenic
w xfor poultry 34 , M. genitalium which might be
associated with non-gonococcal urethritis in humans
w x35 , M. mycoides ssp. mycoides SC which is re-
sponsible for contagious pleuropneumonia in cattle
w x36 , S. citri, the agent of ‘stubborn’ disease of citrus
w x37 , and the honeybee pathogen S. melliferum. A
comparison of the MICs determined for the different
 .peptides Table 2 shows that among the molecules
used in this work, P-series peptides were thoroughly
more active than JM-series peptides. It is noteworthy
that in the case of A. laidlawii, P2 and P3 were more
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potent than P1, and JM133 more potent than JM123.
A comparison of the sequences of these peptides
 .Fig. 1 suggests that shortening the linker between
the hydrophobic N-terminal sequence and the polyca-
tionic C-terminal stretch KKKRK was responsible
for a two-fold increase of the antibiotic activities.
However, the activities of the synthetic peptides were
much lower than those of melittin. In particular, none
of the six mollicutes was capable of resisting the
effect of the bee-venom peptide whereas M. my-
coides ssp. mycoides SC was resistant to all of the
synthetic peptides at concentrations up to 100 mM.
The higher resistance of M. mycoides ssp. mycoides
SC to the synthetic peptides and melittin, and to other
w xnatural peptides 19 might well be due to the pres-
ence of a capsule of galactan on the surface of this
w xmollicute 38 . Indeed, this capsule appears as a
major difference between the surfaces of M. my-
coides ssp. mycoides SC and the other species used
in this study. Conversely, the presence of large
amounts of spiralin on the cell surface of spiroplas-
w xmas 39–42 does not seem to protect these molli-
cutes against membrane-seeking peptides. However,
to clearly assess the protective functions of the cap-
sule and of spiralin, comparisons with galactan-defec-
tive mutants of M. mycoides ssp. mycoides SC and
spiralin-defective mutants of spiroplasmas need to be
performed.
Spiroplasma cell motility and helicity being very
w xsensitive to membrane-seeking peptides 19 , we have
used S. melliferum BC3 to further investigate the
antibacterial activities of the peptides. P1 and JM133
were both capable of deforming S. melliferum cells
but were again much less potent than melittin. The
deforming power of the peptides actually paralleled
their growth inhibition activities. The analysis of the
 .effects on the membrane electrical potential DC
 .and the transmembrane pH gradient DpH of A.
laidlawii and S. melliferum revealed that P-series
peptides were capable of decreasing DC i.e., mak-
.ing the membrane potential less negative and DpH,
but less efficiently than melittin, whereas no effect
could be recorded with JM-series peptides Figs.
.5–7 . These data suggest that both types of peptides
are membranotoxic but only the former have a signif-
icant ionophoric activity in mollicutes. They also
suggest that the MICs determined by the growth
inhibition test in liquid medium probably underesti-
mate the antibiotic activity of peptides since much
lower concentrations were needed to deform spiro-
plasma cells or to de-energise the plasma membrane.
This might be due to the fact that MICs were deter-
mined in culture media whilst cell deformation exper-
iments and measurements of DC and DpH were
performed in cells dispersed in buffer. Since culture
media for mollicutes are complex and usually contain
animal serum, lipoproteins thus supplied to the media
may compete with membranes as targets for the
peptides.
Two main mechanisms have been proposed so far
to explain the lytic activity of melittin for reviews
w x.  .see 12,43 : i The a-helical peptides bind parallel
to the membrane surface and lysis occurs upon the
subsequent formation of transmembrane bundles of
helices delineating hydrophillic pores ‘barrel stave’
.  .model and ii the adsorbed peptides stay oriented
parallel to the surface of the membrane and desta-
bilise this one by burying the helix hydrophobic face
 .into the lipid bilayer ‘wedge’ model . Both mecha-
nisms induce ion leakage and subsequent membrane
lysis. In addition, it is known that at high enough
peptiderlipid ratios and under appropriate conditions,
melittin disrupts membranes into small discs sur-
rounded by a peptide shell, according to a detergent-
w xlike effect 10 . In fact, melittin can probably adopt
these different states when interacting with mem-
branes and several factors including notably the
lipidrmellitin ratio will favour one of these topolo-
w xgies 11 .
It was beyond the scope of the present work to
elucidate the mechanism of peptidermembrane inter-
action in mollicutes. Nevertheless, some clues were
provided by the different studies. CD spectroscopy
 .data Fig. 2A–B, and Table 1 indicate that P-series
peptides adopted a mainly b-sheet conformation in
the presence of liposomes whereas in the same condi-
tions, turns appeared to be the major conformation in
JM-series peptides. If we assume that the conforma-
tions of the peptides in biomembranes are similar to
those observed in liposomes, one may infer that the
mechanisms responsible for the toxicity of P-series
and JM-series peptides are different from those de-
 .scribed for melittin see above since, in the same
conditions, mellitin is essentially a-helical reviewed
w x.in 11 . This interpretation is consistent with the fact
that A. laidlawii membrane thickness had no influ-
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ence on the antibiotic activity of the synthetic pep-
tides whilst that of mellitin was inversely related to
 .membrane thickness Table 3 . However, it should be
noted that even if the activity of melittin depended on
the average thickness of the bilayer, it was still very
 .high MICs3.12 mM on cells exhibiting the thick-
˚ .est membrane hydrophobic core i.e., 28 A . This is
consistent with the observation that melittin interacts
with lipids of different acyl chain lengths provided
that the interaction is initiated in the lipid fluid phase
w x44 , which is the case of mollicutes observed at their
optimal growth temperature.
Furthermore, P-series and JM-series were respon-
sible for spiroplasma cell agglutination, a phe-
nomenon which was not observed with melittin. The
agglutination of the cells by P1 and JM133 suggests
that at least a fraction of these peptides interacted
with the plasma membrane in such a way that the
polycationic C-terminus was exposed on the surface
of the cells, allowing thus the formation of intercellu-
lar ionic bridges. As expected, this phenomenon was
strongly enhanced by increasing the cellrpeptide ra-
tio.
In conclusion, this study shows that the bacterici-
dal activities of melittin and of the synthetic peptides
analysed here were directly related to their ability in
abolishing the transmembrane electrochemical poten-
tial. It remains however to elucidate the molecular
mechanism responsible for the alteration of mem-
brane permeability. This question will be addressed
using NMR spectroscopy for structural investigations
and planar lipid bilayers to analyse membrane perme-
abilisation. Furthermore, we consider the possibility
of improving the antibacterial activity of the synthetic
peptides by derivatisating their C-terminal cys-
teamide function.
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